GeneFerm Biotechnology Co

GeneFerm Biotechnology Co Dividend Coverage

The Dividend Coverage Ratio of GeneFerm Biotechnology Co (1796.TWO) as of Oct 26, 2026 is -0.27. In the previous year, Dividend Coverage Ratio was 1.98 — a change of -113.69% (lower).

Dividend Coverage

-0.27

YoY

-113.69%

Last updated:

Dividend Coverage Ratio of GeneFerm Biotechnology Co is 2024 -0.27 . Dividend Coverage Ratio of GeneFerm Biotechnology Co was 2023 1.98 . It decreases by -113.69% lower compared to the previous year.

The GeneFerm Biotechnology Co Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2022
2.25 TWD
Jan 1, 2023
1.98 TWD
Jan 1, 2024
-0.27 TWD
The GeneFerm Biotechnology Co Dividend Coverage history
YEARDividend CoverageYoY
-0.27-113.69%
1.98-11.97%
2.25—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co., Ltd. generates revenue through the manufacture and sale of health food and supplement products, including fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrate products. The company also offers related manufacturing services, health food design, and research and development services. Its primary customers are consumers seeking health-focused dietary supplements, with a focus on fermented and natural health food solutions. The firm targets health-conscious individuals and wellness-oriented markets through its product portfolio. The business model relies on direct sales of its branded health food products, leveraging the growing demand for natural and fermented dietary supplements. The company's R&D services support product innovation, while manufacturing services cater to partners requiring specialized production capabilities. Health food design services further enhance its offerings for clients in the wellness industry. GeneFerm's revenue streams are derived from both product sales and service-based offerings, with a strong emphasis on fermented health food solutions. The company's focus on medicinal mushrooms and lactic acid bacteria products differentiates its market position, appealing to consumers interested in natural health remedies and probiotic benefits. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

Dividend Coverage Ratio of GeneFerm Biotechnology Co is -0.27 in 2024.

Dividend Coverage Ratio of GeneFerm Biotechnology Co changed from 1.98 to -0.27, representing a -113.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's GeneFerm Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — GeneFerm Biotechnology Co

All Key Metrics — GeneFerm Biotechnology Co